Skip to main content
. 2000 May;156(5):1733–1739. doi: 10.1016/S0002-9440(10)65044-4

Figure 7.

Figure 7.

Effect of anti-ICAM-1 mAb on permeability and leukostasis after intravitreous VEGF injection. ICAM-1 bioactivity was inhibited via intravenous administration of ICAM-1 neutralizing antibody, and retinal permeability (A) or leukostasis (B) were evaluated, respectively. NS, not significant.